Plasma Diplomacy: How Plasma Is Becoming a Strategic Healthcare Commodity
Reza Shojaei, Chief Operating Officer at Canadian Plasma Resources, shared on LinkedIn:
“Plasma Diplomacy: How Plasma Is Becoming a Strategic Healthcare Commodity
For decades, plasma was viewed simply as a life-saving medical resource. Today, it has become something far more powerful: a strategic asset shaping national healthcare security, global trade, and geopolitical influence.
In this issue of Blood and Plasma Pulse, we explore a critical but under-discussed reality:
- Why plasma is no longer just a clinical input, but a tool of national resilience
- How a handful of countries now control the majority of global plasma supply
- What “plasma sovereignty” means for healthcare systems and patient access
- How plasma is influencing international alliances, supply agreements, and policy decisions
As demand for plasma-derived therapies accelerates and supply remains highly concentrated, the question is no longer about who donates plasma but who controls its future.
This edition dives into the emerging concept of Plasma Diplomacy, where healthcare, strategy, economics, and global cooperation intersect through a single biological resource.
Is plasma becoming the next strategic healthcare commodity on the global stage?”
Read full paper here.
Stay updated with Hemostasis Today.
-
Aug 15, 2026, 19:30José Luis Neyro: E4 and DRSP Reduce Hirsutism While Showing Comparable Effects on Thrombin Generation
-
Aug 15, 2026, 19:27Mahmoud Akraym: Don’t Choose Anticoagulation as the Immediate Treatment for Unstable AF
-
Aug 15, 2026, 19:25Ahmed Bennis: DOACs Increase 1-Year Stroke Risk but Reduce MI Risk Compared With Warfarin
-
Aug 15, 2026, 19:24Megan Adediran: An Unwavering Fight for People Living With Haemophilia
-
Aug 15, 2026, 19:23Intravenous Anticoagulation Linked to Worse Early Outcomes After Noncardioembolic Stroke – International Journal of Stroke
-
Aug 15, 2026, 18:03Alejandro González Veliz: Pulmonary Embolism Is Not Always an Anticoagulation-Only Problem
-
Aug 15, 2026, 17:57Ayesha Zia: A New Foundation for Pediatric Pulmonary Embolism Research and Care
-
Aug 15, 2026, 17:50Muhammad Shaheer Bin Faheem: 25 Years of Thromboembolism and Hypertension Mortality
-
Aug 15, 2026, 17:21Bilal Salman։ NETosis as a Therapeutic Target in Inflammation and Thrombosis